Biogen BIIB
$ 145.81
-1.07%
Quarterly report 2024-Q3
added 10-30-2024
Country |
USA |
IPO year |
- |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Michel Vounatsos |
Employees in the company |
7 400 |
Shares |
145 M |
Market Cap[1] |
$ 21.2 B |
EBITDA (LTM) |
$ 2.03 B |
P/E (LTM) |
20.31 |
P/S (LTM) |
2.7 |
EPS (LTM) |
8.92 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.